Institutional investors hold a majority ownership of EXAS through the 96.90% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2014, these large investors purchased a net $16.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIL GESTION SASU Bought 477.00 shares of Exact Sciences Corp
DANSKE BANK A/S (INVESTMENT MANA... Sold 2.3 Thousand shares of Exact Sciences Corp
SATUIT CAPITAL MANAGEMENT LLC Sold 2.9 Thousand shares of Exact Sciences Corp